Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GlycoMimetics (GLYC)
NASDAQ:GLYC
Holding GLYC?
Track your performance easily
GLYC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.14 - $3.53
Previous Close$0.33
Volume1.01M
Average Volume (3M)19.54M
Market Cap
$24.45M
Enterprise Value$2.49M
Total Cash (Recent Filing)$22.40M
Total Debt (Recent Filing)$448.77K
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding64,483,958
10 Day Avg. Volume2,020,726
30 Day Avg. Volume19,543,232
Standard Deviation0.41
R-Squared0.06
Alpha-0.00138
Financial Highlights & Ratios
Price to Book (P/B)1.06
Price to Sales (P/S)2444.59
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue249.46
Enterprise Value/Gross Profit249.46
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
GlycoMimetics News
Ownership Overview
12.64% Insiders
4.98% Mutual Funds
18.28% Other Institutional Investors
59.81% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GLYC FAQ
What was GlycoMimetics’s price range in the past 12 months?
GlycoMimetics lowest stock price was $0.14 and its highest was $3.53 in the past 12 months.
What is GlycoMimetics’s market cap?
Currently, no data Available
When is GlycoMimetics’s upcoming earnings report date?
GlycoMimetics’s upcoming earnings report date is Feb 27, 2025 which is in 98 days.
How were GlycoMimetics’s earnings last quarter?
GlycoMimetics released its earnings results on Nov 07, 2024. The company reported -$0.152 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$0.042.
Is GlycoMimetics overvalued?
According to Wall Street analysts GlycoMimetics’s price is currently Overvalued.
Does GlycoMimetics pay dividends?
GlycoMimetics does not currently pay dividends.
What is GlycoMimetics’s EPS estimate?
GlycoMimetics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlycoMimetics have?
GlycoMimetics has 64,483,955 shares outstanding.
What happened to GlycoMimetics’s price movement after its last earnings report?
GlycoMimetics reported an EPS of -$0.152 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went up 10.526%.
Which hedge fund is a major shareholder of GlycoMimetics?
Currently, no hedge funds are holding shares in GLYC
---
GlycoMimetics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
GLYC Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 16.5%
Last 30 Days ▲ 16.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-78.43%
12-Months-Change
Fundamentals
Return on Equity
-137.20%
Trailing 12-Months
Asset Growth
-70.49%
Trailing 12-Months
Company Description
GlycoMimetics
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
---
GLYC Earnings Call
Q4 2024
0:00 / 0:00
---
GLYC Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Adaptimmune Therapeutics
―
Oncternal Therapeutics
―
Sutro Biopharma
―
Fate Therapeutics
―
Best Analysts Covering GLYC
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-18.22%
reiterated a buy rating 8 months ago
Copying Roger Song's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -18.22% per trade.
---